Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Rovelli

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Recenti Progressi in Medicina|May 17, 2011
[Seborrheic dermatitis in clinical practice]Francesca Rovelli, Santo Raffaele Mercuri, Luigi Naldi
Pain Medicine (Malden, Mass.)|September 22, 2016
Predictors of Responsiveness to Bisphosphonate Treatment in Patients with Complex Regional Pain Syndrome Type I: A Retrospective Chart AnalysisMassimo Varenna, Maria Manara, Francesca Rovelli, et al.
Arthritis Research & Therapy|August 29, 2014
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkersPier Luigi Meroni, Cecilia Beatrice Chighizola, Francesca Rovelli, et al.
Pediatric Rheumatology Online Journal|December 21, 2016
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanerceptSara Verazza, Sergio Davì, Alessandro Consolaro, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Recenti Progressi in Medicina|May 17, 2011
[Seborrheic dermatitis in clinical practice]Francesca Rovelli, Santo Raffaele Mercuri, Luigi Naldi
Pain Medicine (Malden, Mass.)|September 22, 2016
Predictors of Responsiveness to Bisphosphonate Treatment in Patients with Complex Regional Pain Syndrome Type I: A Retrospective Chart AnalysisMassimo Varenna, Maria Manara, Francesca Rovelli, et al.
Arthritis Research & Therapy|August 29, 2014
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkersPier Luigi Meroni, Cecilia Beatrice Chighizola, Francesca Rovelli, et al.
Pediatric Rheumatology Online Journal|December 21, 2016
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanerceptSara Verazza, Sergio Davì, Alessandro Consolaro, et al.
Pageof 1